Fear of impurities is spreading again in the domestic pharmaceutical industry. There is a high risk that the aftermath of large-scale withdrawal of impurities from Canada will also damage Korea. Pharmaceutical companies are nervous in that it is a new type of impurity that is different from the one that has built a verification system over the past three years.
◆Start investigating impurities of new types from Canada and panic because there is no test method
According to the industry on the 7th, pharmaceutical companies are looking at the details of impurities of angiotensin II receptor blockers (ARB) such as Irbesartan, Losartan, and Valsartan.

On the 4th, the Ministry of Food and Dru